Myocardial infarction and individual nonsteroidal anti‐inflammatory drugs meta‐analysis of observational studies

ConclusionsMost frequently NSAIDs used in clinical practice, except naproxen, are associated with an increased risk of AMI at high doses or in persons with diagnosed coronary heart disease. For diclofenac and rofecoxib, the risk was increased at low and high doses. Copyright © 2013 John Wiley & Sons, Ltd.

Source: Pharmacoepidemiology and Drug Safety - April 25, 2013 Category: Drugs & Pharmacology Authors: Cristina Varas‐Lorenzo, Nuria Riera‐Guardia, Brian Calingaert, Jordi Castellsague, Francesco Salvo, Federica Nicotra, Miriam Sturkenboom, Susana Perez‐Gutthann Tags: Review Source Type: research